Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-070461
Filing Date
2025-05-13
Accepted
2025-05-13 16:39:37
Documents
46
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mnov-20250331.htm   iXBRL 10-Q 944195
2 EX-31.1 mnov-ex31_1.htm EX-31.1 15644
3 EX-31.2 mnov-ex31_2.htm EX-31.2 16102
4 EX-32.1 mnov-ex32_1.htm EX-32.1 11446
5 EX-32.2 mnov-ex32_2.htm EX-32.2 11535
  Complete submission text file 0000950170-25-070461.txt   4513132

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mnov-20250331.xsd EX-101.SCH 687704
49 EXTRACTED XBRL INSTANCE DOCUMENT mnov-20250331_htm.xml XML 696280
Mailing Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

EIN.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33185 | Film No.: 25940845
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)